Ampersand Capital Partners, established in 1988 and based in Wellesley, Massachusetts, is a private equity firm that specializes in mid-market investments, primarily focusing on the healthcare and industrial sectors. The firm targets growth opportunities in various areas within healthcare, including laboratory services, laboratory products, contract manufacturing, pharma services, and specialty pharmaceuticals. As a Registered Investment Adviser, Ampersand Capital Partners aims to support the expansion of its portfolio companies through strategic investments and operational improvements.
AnaBios specializes in enabling human-focused drug discovery. As a CRO, AnaBios provides products and services for every stage of drug discovery. Through proprietary technology based on the use of human donor organs and tissues, it studies ex vivo human responses to drugs and further investigate the molecular and functional basis of relevant human physiology. Its research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease, and neurodegeneration.
In partnership with Fortune 500 pharmaceutical companies, contract research organizations, and universities, the company's mission is to develop therapeutic advancements to help patients live longer, healthier, and more productive lives.
Syft Technologies Ltd. develops, markets, and supports air analysis solutions for research teams, commercial laboratories, government agencies, and private companies. The company offers Voice200 SIFT-MS instruments that allow users to identify and measure a range of compounds simultaneously; Sample Collection Case that combines sample collection hardware into one compact and portable package; and Sample Bag Flushing Station that simultaneously cleans sample bags. Its analytical solutions are used in container air analysis; food, flavor, and fragrance; medical research; environmental; and oil and gas exploration market sectors. The company offers its products through a network of distributors in Benelux, Germany, Austria, Switzerland, Italy, and France. Syft Technologies Ltd. was founded in 2002 and is based in Christchurch, New Zealand. The company has locations in Christchurch, New Zealand; Warrington, the United Kingdom; and Pittsburgh, Pennsylvania.
BioEcho Life Sciences develop and produce next-generation technologies and products to enable molecular biology and diagnostics laboratory workflows of higher convenience, higher robustness, and higher sustainability.
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
Genezen Laboratories specializes in contract development and manufacturing for the cell and gene therapy sector, focusing on early-phase process development, viral vector production, and analytical testing services. The company aims to meet the needs of both emerging and established firms within the gene and cell therapy manufacturing market. Genezen's expertise and advanced technological solutions are designed to facilitate the acceleration of breakthrough treatments, leveraging extensive industry knowledge and collaboration with leading institutions. This commitment positions Genezen as a key player in making viral vector production more accessible to a diverse range of clients.
American Laboratory Products offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.
GeneWerk GmbH is a laboratory based in Heidelberg, Germany, specializing in testing for cell and gene therapies. Founded in July 2014 by a team of experts, including Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt, and Dr. Annette Deichmann, the company offers a range of services for preclinical and clinical trial patient sample analysis. Its product offerings include integration site analysis of viral vectors using various techniques, quality control for AAV vectors, immune repertoire analysis, and gene editing analyses. Additionally, GeneWerk provides qPCR services and develops bioinformatics solutions utilizing next-generation sequencing technologies. The company leverages its extensive experience in integration site analysis and high-throughput sequencing to innovate and enhance analytical methods for diverse projects.
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
New England Peptide, Inc. specializes in the design and manufacture of various peptide-related products. The company offers a range of bioactive peptides, amino acids, phospho amino acids, pseudoprolines, and heavy amino acids, along with peptide synthesis accessories. Additionally, it provides stable isotope standard tryptic peptides for protein identification and quantification, exosome isolation products, and both custom polyclonal and monoclonal antibodies. New England Peptide also offers analytical services that include amino acid analysis, liquid chromatography/mass spectrometry, sequencing, and sample preparation. The company primarily serves organizations involved in drug and vaccine discovery and distributes its products online and through partners in Japan, Taiwan, and Korea. Founded in 1998 and headquartered in Harvard, Massachusetts, with an additional office in Cambridge, New England Peptide continues to focus on quality and customer service in the peptide industry.
Manufacturer of peptides and polyclonal antibodies intended for drug, vaccine and diagnostic development organizations. The company offers peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, small molecule organic synthesis and resins for the treatment of cancer, diabetes, obesity, infection and Human Immunodeficiency Virus (HIV), providing quality and customized products.
Provider of coating and surface treatment services intended for the medical device industry. The company offers coating and surface treatment, development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular and other healthcare end-markets, enabling the medical device industry to utilize a variety of critical settings to improve material characteristics such as wear and fretting resistance, corrosion resistance, fracture toughness, lubricity, infection resistance, biocompatibility, aesthetics and radiopacity.
Vibalogics GmbH is a contract development and manufacturing organization based in Cuxhaven, Germany, specializing in complex live biological products. Founded in 2002, the company provides comprehensive services, including process development, manufacturing, and fill and finish operations for biopharmaceutical companies. Vibalogics supports the development of therapeutic and prophylactic vaccines, as well as oncolytic viral therapies and gene therapies. The organization collaborates with pharmaceutical companies, biotech firms, and academic institutions across Europe, the United States, and the Asia-Pacific region. Previously known as Bioprotect Research GmbH, the company rebranded to Vibalogics in January 2007 and operates as a subsidiary of Ampersand Management LLC.
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests and services, analysis software and education. The company is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation offering high resolution HLA typing methods for Sanger and NGS techniques.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.
MedPharm Ltd. specializes in pharmaceutical research and development services, focusing on topical and transdermal products for various applications, including dermatological, nail, eye, airway, and mucosal membrane treatments. The company offers a range of drug delivery technologies, such as MedSpray, an aerosol system designed for immediate or sustained delivery. MedPharm's comprehensive services encompass target product profiling, active pharmaceutical ingredient (API) characterization, bio-analysis, pre-formulation, formulation optimization, and clinical supply manufacturing. Additionally, the company conducts efficacy and toxicity testing, as well as analytical services to ensure product stability and compliance with regulatory standards. With a global presence serving clients in regions including the United States, Europe, and Asia, MedPharm has established itself as a leader in the development of innovative and cost-effective solutions for drug delivery. Founded in 1999 and headquartered in Guildford, United Kingdom, with an office in Durham, North Carolina, MedPharm continues to advance the field of pharmaceutical development through its expertise and research capabilities.
Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products for cell analysis in life science and biomedical research. Established in 2003 and based in Lawrence, Massachusetts, the company provides a range of products including the Cellometer, which assists in counting and analyzing cell lines and primary cells using bright field and fluorescence imaging, and the Celigo, a high-throughput image cytometry system designed for both adherent and suspension cells in microwell plates. Nexcelom also offers fluorescent reagents and kits for cell counting and cell-based assays. Its products cater to various research fields, including immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation, serving the broader life science industry.
Detector Technology, Inc. is a world-class leading manufacturer of products and systems for OEM and equipment manufacturers. DeTech specializes in Channel Electron Multipliers, Glass Extrusion & Fabrication and Motion Control Products. With a state of the art fabrication and production facility, our dedicated team has been delivering excellence in manufacturing and customer satisfaction over the last 20 years.
Adaptas Solutions is a strategic supplier that focuses on providing contract manufacturing services for analytical and laboratory equipment. The company specializes in essential components and subsystems for gas chromatography, mass spectrometry, and liquid chromatography applications. Its offerings include the development of critical mass spectrometry components such as electron multipliers, filaments, power supplies, and ion optic grids. Additionally, Adaptas Solutions provides liquid handling and lab automation components, allowing manufacturers of analytical equipment to integrate high-quality products into their production processes.
LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. The company's range of services covering areas such as antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing and bioanalytics focus on integrated platforms to support projects throughout the drug discovery process and offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal enabling clients to accelerate product development from lead discovery to Phase 1 clinical trials. Located in the heart of the San Francisco Bay Area, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to its customers. The production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director to ensure timely completion with superior results and transparent communication. Clients have real-time access to their project data and can view and receive status updates through LakePharma’s secure cloud-based Datasystems. LakePharma follows the principles of Good Laboratory Practices (GLP) to ensure the quality, reliability and integrity of study data. Upon request, services can also be performed in full compliance with FDA documentation requirements for submissions for nonclinical laboratory studies. All services are provided solely on a fee-for-service basis and are royalty-free.
Corpus Medical Inc. specializes in consulting services for the medical device industry, offering expertise in the design, development, and manufacturing of advanced technology catheters. The company focuses on supporting device manufacturers in the electrophysiology, peripheral vascular, and cardiovascular markets. Its contract development and manufacturing services are tailored to the creation and commercialization of innovative interventional medical devices and catheter-based delivery systems. By streamlining the process from concept to market, Corpus Medical aims to enhance the efficiency with which customers can bring their products to market.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Alcami Corporation is a contract development and manufacturing organization (CDMO) based in Wilmington, North Carolina, specializing in providing comprehensive services to small and mid-sized pharmaceutical and biotechnology companies. The company offers a range of services, including sterile fill-finish development, oral solid dose development, formulation and analytical development, as well as laboratory testing and microbial identification. By streamlining processes and offering cost-effective solutions, Alcami enables its clients to achieve a more efficient pathway for product commercialization.
Brammer Bio, LLC specializes in developing and manufacturing cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, scale-up, and clinical and commercial supply of drug substances and formulated products. With a focus on autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications, Brammer Bio supports biopharma clients in accelerating the delivery of innovative medicines. The company operates a 45,000 square foot facility in Alachua, Florida, and is expanding with a new 50,000 square foot facility in Lexington, Massachusetts, which will feature large-scale manufacturing suites and laboratories for both clinical and commercial purposes. Established in 2013 and formerly known as Brammer Biopharmaceuticals, Brammer Bio became a subsidiary of Thermo Fisher Scientific in 2019.
Avista Pharma Solutions is a contract testing, development, and manufacturing organization that provides essential services to clients in the pharmaceutical, animal health, and medical device sectors. With over 200,000 square feet of laboratory and manufacturing space across locations in Agawam, MA, Durham, NC, and Longmont, CO, the company specializes in a comprehensive range of scientifically differentiated offerings. These services include early-stage drug development, active pharmaceutical ingredient (API) and drug product development, as well as cGMP manufacturing. Additionally, Avista Pharma provides stand-alone analytical and microbiology testing support, positioning itself as a valuable partner in the creation and production of new medicinal drugs.
Protein Technologies is a manufacturer specializing in peptide synthesizers and reagents. The company designs and supplies these products to a diverse clientele that includes academic institutions, biotechnology firms, pharmaceutical companies, and peptide houses. By providing high-quality tools and materials, Protein Technologies supports researchers in their efforts to advance scientific knowledge and develop new therapies.
GeneWerk GmbH is a laboratory based in Heidelberg, Germany, specializing in testing for cell and gene therapies. Founded in July 2014 by a team of experts, including Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt, and Dr. Annette Deichmann, the company offers a range of services for preclinical and clinical trial patient sample analysis. Its product offerings include integration site analysis of viral vectors using various techniques, quality control for AAV vectors, immune repertoire analysis, and gene editing analyses. Additionally, GeneWerk provides qPCR services and develops bioinformatics solutions utilizing next-generation sequencing technologies. The company leverages its extensive experience in integration site analysis and high-throughput sequencing to innovate and enhance analytical methods for diverse projects.
GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory services.
From the company’s founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value. Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare. Easily accessible around the world, GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government, and clinical institutions.
At GENEWIZ, it is their mission to contribute to the advancement of life sciences and technologies. Together with their clients, they can make a difference in the pursuit of scientific discoveries, better healthcare, a greener environment, and abundant food supplies. Their goal is to be the best in the world and the best for the world.
Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan.
Azurity Pharmaceuticals is a developer of drug products and technologies to address the needs of patients. Its drug products such as antimicrobial, mouthwashes, and testosterone enable pharmacists to prepare drugs for those populations who are in need of a better alternative to traditionally-compounded medications.
Elite One Source Nutritional Services, Inc. is a company that specializes in contract manufacturing for nutritional and dietary supplements. Founded in 2013 and headquartered in Missoula, Montana, the company operates as a subsidiary of DCC Health & Beauty Solutions Limited. Through its services, Elite One Source supports the production of a wide range of health-focused products, catering to the growing demand in the dietary supplement market.
Nutramed, Inc. develops, manufactures, and markets tablet, capsule, and powder nutritional supplement products for customers in the United States and internationally. It offers a range of manufacturing services, including blending, granulation, tableting, timed release formulation, bilayer tablets, various types of tablet coatings, two-piece hard-shell encapsulation, stick-packs, multi-packs, blister cards, pack out, powder packaging, and tablet and capsule packaging. The company also offers enteric coating on tablets, capsules, and soft gels. The company was founded in 1998 and is headquartered in Chino, California
Sanova Dermatology, PLLC is a dermatology practice based in Austin, Texas, that specializes in both cosmetic and medical skin care services. The company provides a comprehensive range of treatments, including wrinkle reduction, acne management, mole removal, and skin cancer treatment. Sanova Dermatology focuses on delivering individualized care, ensuring that patients receive tailored skin-care solutions from a team of medical experts. The practice aims to meet the aesthetic and medical needs of its patients while maintaining a commitment to fair pricing and high-quality care.
Bioventus LLC develops and/or markets orthobiologic solutions for bone fusion and osteoarthritis. Its active healing therapies product line supports accelerated and more complete healing of bone fractures, and treats the chronic pain associated with osteoarthritis; and bone healing solutions work to enhance the body’s natural healing process. The company also provides injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient; and surgical orthobiologics. Its products are available through a network of distributors. The company was incorporated in 2011 and is based in Durham, North Carolina. Bioventus LLC operates as a subsidiary of Bioventus Inc.
Bioventus LLC develops and/or markets orthobiologic solutions for bone fusion and osteoarthritis. Its active healing therapies product line supports accelerated and more complete healing of bone fractures, and treats the chronic pain associated with osteoarthritis; and bone healing solutions work to enhance the body’s natural healing process. The company also provides injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient; and surgical orthobiologics. Its products are available through a network of distributors. The company was incorporated in 2011 and is based in Durham, North Carolina. Bioventus LLC operates as a subsidiary of Bioventus Inc.
Nitinol Devices & Components (NDC) is a privately held medical device company based in Fremont, California. The company specializes in Nitinol technology, which includes the manufacturing, research, development, and regulatory support for shape-memory and superelastic Nitinol products. NDC is actively expanding its capabilities to address the increasing demand within the medical field for these advanced materials. By focusing on comprehensive technical support and innovative solutions, NDC aims to enhance its offerings and strengthen its position in the medical device industry.
Blue Sky Biotech, Inc. is a Contract Research Organization (CRO) in the pharmaceutical R&D market. As a trusted partner to nine of Fortune’s Top 10 Pharmaceutical Companies, Blue Sky has a proven track record with industry leaders. Blue Sky aims to alleviate the onerous and labor-intensive tasks that take scientists away from key experimentation, novel theory exploration and other optimal uses of their time. Blue Sky is synonymous with productivity in the early discovery biology processes known as genetic cloning, recombinant protein expression and laboratory-scale fermentation (scale-up bioprocessing). We are motivated by our ability to impact the overall efficiency of the drug discovery process, thus contributing to a longer, healthier lifespan for human beings.
FirstRain, Inc. specializes in business analytics solutions that cater to Fortune 1000 companies, helping them enhance their strategies, generate leads, and uncover new sales opportunities while identifying potential risks. Founded in 2000 and headquartered in San Mateo, California, FirstRain offers a cloud-based platform that transforms decision-making processes for sales, marketing, and finance professionals. Its advanced analytics technology leverages business-focused web and social media data, integrating seamlessly with leading CRM and social enterprise platforms such as Salesforce.com and Microsoft Dynamics. The company also incorporates its intelligence into prominent research platforms. In addition to its San Mateo headquarters, FirstRain maintains offices in New York and Gurgaon, India. As of July 2017, it operates as a subsidiary of Ignite Technologies, Inc.
Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.
FirstRain, Inc. specializes in business analytics solutions that cater to Fortune 1000 companies, helping them enhance their strategies, generate leads, and uncover new sales opportunities while identifying potential risks. Founded in 2000 and headquartered in San Mateo, California, FirstRain offers a cloud-based platform that transforms decision-making processes for sales, marketing, and finance professionals. Its advanced analytics technology leverages business-focused web and social media data, integrating seamlessly with leading CRM and social enterprise platforms such as Salesforce.com and Microsoft Dynamics. The company also incorporates its intelligence into prominent research platforms. In addition to its San Mateo headquarters, FirstRain maintains offices in New York and Gurgaon, India. As of July 2017, it operates as a subsidiary of Ignite Technologies, Inc.
Agilux Laboratories, Inc. is a contract research organization based in Worcester, Massachusetts, founded in 2007. The company specializes in supporting drug discovery, pre-clinical, and clinical research for the biotech and pharmaceutical industries. Agilux Laboratories offers a comprehensive range of services, including drug metabolism and pharmacokinetics (DMPK), discovery bioanalytical, good laboratory practice (GLP) bioanalytical, as well as in vivo and in vitro testing. The organization also provides immunoassays for biomarker analysis. By focusing on bioanalytical and pharmacokinetic/pharmacodynamic testing, Agilux Laboratories assists its clients in navigating the complexities of drug development and regulatory requirements. The company operates as a subsidiary of Charles River Laboratories International, Inc.
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.
ChanTest has developed the world's most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. Services range from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process – to a complete set of in vitro GLP service products for cardiac risk assessment. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately – to help make better, safer drugs.
Cequent Pharmaceuticals is an early-stage biopharmaceutical company located in Cambridge, Massachusetts, focusing on the development of novel therapeutics to prevent and treat various human diseases, including inflammatory diseases and cancer. The company's proprietary technology, known as TransKingdom RNA interference (tkRNAi), is designed to safely and effectively deactivate specific disease-causing genes by utilizing non-pathogenic bacteria to produce and deliver RNA interference directly into cells. Cequent's initial drug candidates are currently in pre-clinical development, targeting colon-cancer prevention and inflammatory bowel disease. The foundational research behind its tkRNAi technology originates from prestigious institutions, including the Institut Pasteur in Paris and the Beth Israel Deaconess Medical Center at Harvard Medical School. Established in 2006, Cequent Pharmaceuticals was acquired by Marina Biotech, Inc. in 2010.
CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.
Magellan Diagnostics, Inc. is a medical device company focused on developing and manufacturing point-of-care systems and clinical laboratory instruments for lead testing. The company offers a range of products, including LeadCare II, a blood lead testing system, and LeadCare Ultra, designed for laboratory use. Additionally, LeadCare Plus serves facilities with lower testing volumes. Magellan also provides analytical services related to lead and heavy metal exposure, aiding in the monitoring of exposure for employees and the general public. Founded in 2004 and headquartered in Billerica, Massachusetts, Magellan has its roots in the late 1960s with the development of a novel blood lead measurement technique by MIT graduates. The company has since evolved to create portable instruments that enhance accessibility to lead testing in various settings, helping to identify and protect individuals at risk of lead exposure.
FirstRain, Inc. specializes in business analytics solutions that cater to Fortune 1000 companies, helping them enhance their strategies, generate leads, and uncover new sales opportunities while identifying potential risks. Founded in 2000 and headquartered in San Mateo, California, FirstRain offers a cloud-based platform that transforms decision-making processes for sales, marketing, and finance professionals. Its advanced analytics technology leverages business-focused web and social media data, integrating seamlessly with leading CRM and social enterprise platforms such as Salesforce.com and Microsoft Dynamics. The company also incorporates its intelligence into prominent research platforms. In addition to its San Mateo headquarters, FirstRain maintains offices in New York and Gurgaon, India. As of July 2017, it operates as a subsidiary of Ignite Technologies, Inc.
Ortho Organizers
Seed Round in 2006
Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.
Assay Designs
Series A in 2005
Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.
Medifacts International
Series A in 2005
As of February 5, 2010, Medifacts International, Inc. was acquired by CoreLab Partners. Medifacts International, Inc. provides cardiovascular safety monitoring services to the pharmaceutical and biotech industry. The company offers electrocardiogram (ECG) services, digital Holter services, ambulatory blood pressure monitoring, automated blood pressure, telemedicine, and assessment of arterial stiffness in clinical trials, as well as glucose monitoring and pulmonary services. It also provides consulting and medical writing services, including expert program and protocol design, protocol development, expert interim reports, statistical analysis plans and reports, ECG analysis, regulatory guidance and support, expert summary reports for inclusion in the clinical study reports, and statistical analysis planning and biostatistics, as well as digital data collection, transmission, and analysis. The company was founded in 1985 and is headquartered in Rockville, Maryland with additional offices in Langenfeld, Germany; and Shanghai, China.
Talecris Biotherapeutics is a biopharmaceutical company that produces and markets plasma-derived protein therapies. Talecris Biotherapeutics was founded in 2004 and is based in Barcelona, Spain.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
ESA Bioscience
Acquisition in 2004
ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The companys discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Proficiency, Inc. provides product knowledge integration and CAD interoperability solutions that enable manufacturers and suppliers to share product knowledge from various engineering and manufacturing environments. Its solutions include product knowledge migration, which delivers a process of technology and methodology that meets migration needs; and supplier delivery solutions to original equipment manufacturers or higher tier suppliers. The company’s products also include Collaboration Gateway V7.0, which enables the transfer of the product knowledge between CAD systems that include geometry, features, sketches, manufacturing info, metadata, assembly information, and drawings in the conversion process; and Completion Wizard, which provides an interactive method of completing the process. In addition, it offers CAD translation services, such as geometry-only, product knowledge, and associative drawing translations; consulting services, such as migration strategy, supplier delivery strategy, and process integration consulting; and implementation services, such as training, customer support, and customer specific developments. The company serves various companies in the automotive, aerospace and defense, and heavy machinery industries. Proficiency, Inc. was founded in 1998 and is based in Marlborough, Massachusetts. As of July 1, 2009, Proficiency, Inc. operates as a subsidiary of ITI TranscenData.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.
FirstRain, Inc. specializes in business analytics solutions that cater to Fortune 1000 companies, helping them enhance their strategies, generate leads, and uncover new sales opportunities while identifying potential risks. Founded in 2000 and headquartered in San Mateo, California, FirstRain offers a cloud-based platform that transforms decision-making processes for sales, marketing, and finance professionals. Its advanced analytics technology leverages business-focused web and social media data, integrating seamlessly with leading CRM and social enterprise platforms such as Salesforce.com and Microsoft Dynamics. The company also incorporates its intelligence into prominent research platforms. In addition to its San Mateo headquarters, FirstRain maintains offices in New York and Gurgaon, India. As of July 2017, it operates as a subsidiary of Ignite Technologies, Inc.
Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.
Viadux is a prominent provider of in-building broadband access solutions tailored for the telecommunications and cable sectors. The company collaborates with service providers to facilitate the delivery of high-speed data, video, and voice services to small-to-medium enterprises and residential customers, particularly within the Multi-Tenant Unit (MTU/MDU) market. Based in Australia, Viadux operates as a subsidiary of Reece Limited and has a history of involvement in steel water pipes and fittings, reflecting its diverse operational background.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
Ensemble Communications
Venture Round in 2002
Ensemble Communications develops wireless infrastructure equipment for high-speed local broadband access applications.
Cyclis Pharmaceuticals
Series A in 2002
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.
Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing. They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.
Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.
Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.
ACLARA BioSciences
Seed Round in 1996
Aclara Biosciences develops lab-on-a-chip technologies for use in genomics research and pharmaceutical drug screening. ACLARA Biosciences provides assay chemistry solutions for drug discovery and development, providing critical high-value information about the expression and interaction of genes and proteins within cells. ACLARA is dedicated to unlocking the power of pathway biology to identify highly specific protein-based biomarkers, accelerate the development of next-generation targeted therapeutics, and recognize the most appropriate patients for approved therapies, thereby enabling physicians to create personalized treatment regimens for patients suffering from cancer and other life-threatening diseases. Aclara Biosciences Inc. was founded in 1995 and is based in Mountain View, California. As of December 10, 2004, Aclara Biosciences Inc. was acquired by Monogram Incorporated.
American Laboratory Products offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.
Confluent Medical is a manufacturer of catheter medical devices located in Fremont, California. The company produces a diverse range of medical devices, systems, and equipment designed for the healthcare industry. Its product portfolio includes surgical components, balloon expandable stents, catheters, balloon production equipment, testing apparatus, access kits, biomedical textiles, and guidewires. Confluent Medical focuses on providing advanced technological solutions that aim to improve patient care and facilitate better recovery outcomes.
Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information.
Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.
Nexelis is a prominent provider of assay development and advanced laboratory testing services, catering primarily to pharmaceutical, biotech, and in-vitro diagnostic manufacturing companies. The company specializes in biomarker testing and offers a range of services, including clinical trial support, diagnostic product development, and lab certifications. Nexelis focuses on delivering customized solutions tailored to meet specific project requirements, ensuring that clients receive targeted support throughout their development processes. As a portfolio company of Ampersand Capital Partners, Nexelis is positioned to enhance its offerings and expand its impact in the life sciences sector.
Magellan Diagnostics, Inc. is a medical device company focused on developing and manufacturing point-of-care systems and clinical laboratory instruments for lead testing. The company offers a range of products, including LeadCare II, a blood lead testing system, and LeadCare Ultra, designed for laboratory use. Additionally, LeadCare Plus serves facilities with lower testing volumes. Magellan also provides analytical services related to lead and heavy metal exposure, aiding in the monitoring of exposure for employees and the general public. Founded in 2004 and headquartered in Billerica, Massachusetts, Magellan has its roots in the late 1960s with the development of a novel blood lead measurement technique by MIT graduates. The company has since evolved to create portable instruments that enhance accessibility to lead testing in various settings, helping to identify and protect individuals at risk of lead exposure.
Adaptas Solutions is a strategic supplier that focuses on providing contract manufacturing services for analytical and laboratory equipment. The company specializes in essential components and subsystems for gas chromatography, mass spectrometry, and liquid chromatography applications. Its offerings include the development of critical mass spectrometry components such as electron multipliers, filaments, power supplies, and ion optic grids. Additionally, Adaptas Solutions provides liquid handling and lab automation components, allowing manufacturers of analytical equipment to integrate high-quality products into their production processes.
Vibalogics GmbH is a contract development and manufacturing organization based in Cuxhaven, Germany, specializing in complex live biological products. Founded in 2002, the company provides comprehensive services, including process development, manufacturing, and fill and finish operations for biopharmaceutical companies. Vibalogics supports the development of therapeutic and prophylactic vaccines, as well as oncolytic viral therapies and gene therapies. The organization collaborates with pharmaceutical companies, biotech firms, and academic institutions across Europe, the United States, and the Asia-Pacific region. Previously known as Bioprotect Research GmbH, the company rebranded to Vibalogics in January 2007 and operates as a subsidiary of Ampersand Management LLC.
Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests They offer are driven by rigorous, validated science. They power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests They offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Dynex Technologies, Inc. specializes in the design, engineering, manufacturing, and distribution of fully automated ELISA microplate workstations, laboratory instruments, and related consumables and accessories. The company's products are aimed at enhancing laboratory efficiency and accuracy in various scientific and clinical applications. Dynex Technologies also provides technical support services to ensure optimal use of its equipment. Operating from Chantilly, Virginia, the company serves a global market, distributing its products through a network of distributors across North America, South America, Europe, Asia, the Middle East, and Africa, as well as through online channels. Established in 1952 and formerly known as Dynatech Laboratories, Dynex Technologies has evolved to meet the increasing demands of the laboratory industry, enabling scientists and clinicians to achieve improved health outcomes through advanced detection and automated sample handling solutions.
MedVenture Technology specializes in the development and manufacturing of minimally invasive surgical devices and catheter-based devices. The company partners with medical device companies to provide co-development services, ensuring a collaborative approach to product development. MedVenture emphasizes consistent communication, precise evaluations, and expert execution in its operations, which positions it as a leader in the medical device industry. Through its focus on detail and partnership, MedVenture aims to meet the diverse manufacturing needs of its clients effectively.
Innovative Food Processors is a domestic manufacturer specializing in high-performance powders and encapsulated food and nutrition ingredients. The company focuses on developing agglomerated and microencapsulated products that provide enhanced taste, performance, and nutritional benefits. With a commitment to innovation, Innovative Food Processors employs advanced particle engineering technologies to create customized solutions that meet the specific needs of clients. Their integrated approach serves as a one-stop shop for food, dietary supplement, sports nutrition, and medical food companies, offering products with precise nutritional composition, tailored sensory characteristics, and optimized functionality. This enables their clients to deliver high-performance products to consumers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.